Anterior Cruciate Ligament RuptureNCT06189573
Reconstruction of the ACL With QT Graft With Bone Plug vs BPTB
A study testing Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graft and Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graft in people with Anterior Cruciate Ligament Rupture, run by Instituto Nacional de Rehabilitacion at 1 site in Mexico.
Trial summary
Background: Anterior cruciate ligament (ACL) injury is one of the most common orthopedic injuries worldwide. Currently, the use of the bone patellar tendon bone graft (BPTB) technique is considered the gold standard. Read more about this study
- Who is it for?
- Ages 15 to 55 years
- Conditions the study is for
- Anterior Cruciate Ligament Rupture
- What is being tested?
- Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graft and Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graft
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteMexico
- Study dates
- 18 Dec 2023to 30 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 55 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Men and women from 15 to 55 years old.
- Primary ACL rupture diagnosed by MRI.
- INR-LGII patients with a complete institutional record.
- Without the presence of systemic, chronic degenerative comorbidities that could affect the quality of the graft. (Diabetes, Thyroid, Autoimmune diseases).
Who cannot join
- Grade 2 or 3 posterior cruciate ligament injuries.
- Multiligamentous injuries.
- Severe varus/valgus deformities (mechanical axis outside the range of 35% to 65% of the articular surface of the tibia).
- Previous knee surgeries to be treated.
- Anterior knee pain present (VAS greater than 6), with brush and escape maneuvers positive.
- K\&L osteoarthritis ≥ 2 in the knee to be treated.
Show all 21Show fewer
- History of intra-articular fractures of the injured knee.
- History of ACL injury and/or surgery in the contralateral knee.
- Previous injury to the patellar or quadriceps tendon (total or partial rupture).
- Symptomatic extensor mechanism tendinopathies.
- High patella (Caton-Deschamps index 1.2 mm)
- ICRS grade III or IV chondral lesion in patella greater than 1cm 2
- Medical conditions that prevent full patient participation (e.g. cancer active, rheumatoid arthritis, etc.)
- Pregnancy.
- Obesity (WCC >30).
- Perioperative elimination criteria:
- Medial or lateral meniscus injury >50% non-repairable.
- Medial and/or lateral menisectomy > 50%
- Grade 2-3 ligament instability associated with ACL injury.
- Cartilage lesion >2 cm2 ICRS grade 3-4, untreated.
- Associated surgeries due to instability.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Mexico1 site
Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra
Mexico City, Mexico City, 14389
About this study
Official title: Reconstruction of the Anterior Cruciated Ligament With Quadriceps Tendon Graft With Bone Plug vs Bone Patellar Tendon Bone Graft, a Randomized Clinical Controlled Essay With 2 Years of Follow up
Background: Anterior cruciate ligament (ACL) injury is one of the most common orthopedic injuries worldwide. Currently, the use of the bone patellar tendon bone graft (BPTB) technique is considered the gold standard. The use of the quadriceps tendon graft (QT) has gained greater interest in recent years, this because with an adequate technique it is possible to obtain a biomechanically superior graft with fewer adverse events. The objective of this study is to compare the objective and subjective clinical results, as well as the presence or not of adverse events in ACL reconstruction with these 2 types of grafts in the medium term.
Materials and methods: Controlled, longitudinal, prospective, randomized, double-blind clinical trial that will include patients of both sexes, between 15 and 55 years of age, with primary ACL injury who attend the outpatient clinic of the Sports Orthopedics Service. INRLGII arthroscopy between October 2023 and October 2025, prior informed consent. Graft selection will be done randomly 1:1 between bone-tendon-bone (BPTB) graft Vs. quadriceps tendon graft (QT) for ACL reconstruction surgery. The clinical evaluation of the patients Will be done by 2 blinded evaluators, through the objective measurement of KT-1000 and the use of subjective clinical knee scales, both preoperatively and at 3-6-12 and 24 months. The presence or absence of adverse events or complications will be documented during a minimum of 2 years of follow-up. Parametric and non-parametric statistical tests will be used depending on whether the distribution is normal or not, for dependent and independent groups, using the SPSS version 25 statistical program.
Read the detailed description
JUSTIFICATION ACL rupture is one of the most frequent and studied injuries in orthopedic literature. Various short-, medium- and long-term results of ACL reconstruction have been described in the international literature, as well as comparisons between different types of reconstruction techniques, grafts and complications.
The vast majority of studies and clinical trials focus on BPTB and hamstrings tendon (HT), the former being considered by multiple authors as the gold standard for the management of these injuries despite its association with high donor site morbidity such as anterior knee pain, pain when kneeling and muscle weakness.
With an adequate surgical technique for both graft harvesting and ACL reconstruction, the use of QT as a graft has reported good biomechanical and clinical results and even superior to other grafts. However, despite this, at present a precise justification has not been established that defines the advantages or disadvantages of choosing this graft over other popular techniques, which is why a randomized study was carried out in a center of high specialty and concentration of patients with this type of lesions will increase the level of scientific validation of the information available regarding the use of this graft.
PROBLEM STATEMENT Is there a statistically significant difference between both techniques (BPTB and QT) at 2 years? Minimum follow-up regarding clinical evolution measured with IKDC, objective stability measured by KT-1000, and adverse events in primary ACL reconstruction?
HYPOTHESIS In patients with anterior cruciate ligament (ACL) injury who undergo surgery reconstruction with the use of autologous quadriceps tendon with bone plug (QT) or bone patellar tendon bone (BPTB) graft, there will be no statistically significant difference between them, in the first 2 years of follow-up, in terms of clinical evolution measured by the International subjective scale Knee Documentation Committee (IKDC), nor objective stability measured by arthrometry with the KT1000 device; In addition, there will be fewer adverse events in patients in whom quadriceps tendon graft (QT) was used compared to bone patellar tendon bone graft (BPTB).
GENERAL OBJECTIVE Observe if there is a statistically significant difference between both QT and BPTB grafts in terms of clinical evolution measured by IKDC, and objective stability measured by KT-1000, as well as reporting adverse events in both groups at 2 years of follow-up.
MATERIAL AND METHODS Controlled, longitudinal, prospective, randomized, double-blind clinical trial that will include patients from the Luis Guillermo Ibarra-Ibarra National Rehabilitation Institute (INRLGII) of the Sports Orthopedics and Arthroscopy service, with primary ACL injury who undergo surgery with a consistent procedure in ACL reconstruction either with the use of bone patellar tendon bone graft or quadriceps tendon with bone pad in the period from October 2023 to October 2025. When a patient who requires ACL reconstruction surgery is scheduled in our service, if he meets With the inclusion criteria, you will be invited to participate in the study and if you accept and give your written informed consent you will be included in the study. The selection of the graft to be used will be carried out randomly with a box with a closed envelope, which contains the same number of envelopes with one or another type of graft, and the resulting option will be the way in which the type of graft is assigned. graft, which will not be disclosed to the patient during the period of the study. During the surgical procedure, the repair of concomitant injuries (meniscal or chondral) will be carried out, and at the end of the surgery, the surgeon will prepare the surgical report sheet detailing the findings found and the characteristics of the graft used in terms of thickness, length , and the presence or absence of incidents during surgery.
Subjective clinical scales from IKDC, Kujala, Lysholm, Tegner, and KOOS will be applied. Measurement of the anterior translation of the tibia will be performed objectively with the use of the KT-1000 device.
Subjective and objective clinical evaluations with KT-1000 will be carried out preoperatively and postoperatively at 3, 6, 12 and 24 months by 2 evaluators who will be blinded to the type of graft used in each patient, for which the anterior part of his knee will be covered with a 20cm long "micropore" band, so that the type of graft cannot be identified by the evaluator based on the area of the knee and surgical scar. Clinical follow-up of the patient will also be carried out, in the necessary weeks or months at the discretion of the surgeon or treating doctor, as is usually carried out in the clinical practice of the institute.
Non-contrast magnetic resonance imaging (MRI) studies will be performed to evaluate the integrity of the ACL graft, by an orthopedic evaluator with experience in musculoskeletal imaging, blinded to the type of graft used, to classify it as: intact graft, graft with partial injury to its fibers or graft with complete injury to its fibers. Knee radiographs will also be performed (AP projection in standing position, lateral at 30° of flexion and axial of the patella at 40°), preoperatively and 12 and 24 months after surgery, which will be evaluated by an orthopedic evaluator with experience in musculoskeletal imaging. , blinded to the type of graft used, to evaluate the presence or absence of Osteoarthritis according to the Kellgren \& Lawrence classification, in grades 0 to 4.
All patients will be subjected to the same rehabilitation protocol during the first 3-4 months after surgery, as well as follow-up by sports medicine both pre-surgery and from the 3rd to 4th post-surgical month to receive the same muscle strengthening protocol established in our Institute for patients undergoing ACL reconstruction surgery. Keeping a record of the evaluation of preoperative and postoperative quadriceps strength in a standardized and objective manner through isokinetic evaluation with Cybex.
The use of a mechanical knee brace locked to the operated on knee will not be required on a routine basis, unless there is some indication of its use by the treating surgeon to protect associated injuries that require it, and in that case the use of It will be for a period of no more than 6 weeks. Patients must perform assisted ambulation with the use of crutches for the first 2 weeks with partial support of the operated leg and will subsequently progress to full support, as long as there is no contraindication on the part of the treating surgeon in relation to the management of associated injuries.
The presence or absence of adverse events or complications will be documented during 2 years of minimal monitoring. Parametric and non-parametric statistical tests will be used depending on whether the case has a normal distribution or not, for dependent and independent groups, of the related variables that are the result of periodic evaluations (3, 6, 12 and 24 months) of the same technique. either QT or BPTB, using the SPSS statistical program version 25.
- Conditions
- Anterior Cruciate Ligament Rupture
- Being tested
- Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graft, Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graft
- Keywords
- Anterior Cruciate Ligament Reconstruction, Bone patellar tendon bone graft, Quadriceps tendon graft, KT-1000, IKDC
- Medical subject headings
- Anterior Cruciate Ligament Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graftProcedure or surgery
Surgical reconstruction of anterior cruciate ligament with autologous quadriceps tendon graft
Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graftProcedure or surgery
Surgical reconstruction of anterior cruciate ligament with autologous bone patellar tendon bone graft
| Study group | Role | What they receive |
|---|---|---|
| Quadriceps Tendon graft | Other | Patients with ACL reconstruction with the use of quadriceps tendon graft Receives: Procedure: Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graft |
| Bone Patellar Tendon Bone Graft | Other | Patients with ACL reconstruction with the use of bone patellar tendon bone graft Receives: Procedure: Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graft |
What is being measured
The primary outcome is the main question the study is designed to answer.
International Knee Documentation Committee score (IKDC)
Minimum value 0 Maximum value 100 Higher scores mean a better outcome Subjective assesment. Three categories are examined by the questionnaire: symptoms, athletic activity, and knee function
Measured: Presurgical, 3, 6, 12 and 24 postsurgical months
KT-1000
Device for objective stability measurement.
Measured: Presurgical, 3, 6, 12 and 24 postsurgical months
Secondary outcomes (4)
Anterior Knee Pain Scale (Kujala score)
Minimum value 0 Maximum value 100 Higher scores mean a better outcome Subjective assesment for anterior knee pain
Measured: Presurgical, 3, 6, 12 and 24 postsurgical months
Lysholm Knee Scoring Scale
Minimum value 0 Maximum value 100 Higher scores mean a better outcome Subjective assesment for knee instability
Measured: Presurgical, 3, 6, 12 and 24 postsurgical months
Tegner Activity Scoring Scale
Minimum value 0 Maximum value 10 Higher scores mean a better outcome Activity assesment
Measured: Presurgical, 3, 6, 12 and 24 postsurgical months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Minimum value 0 Maximum value 100 Higher scores mean a better outcome Subjective assesment for knee injuries
Measured: Presurgical, 3, 6, 12 and 24 postsurgical months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jan 2024
- Study start18 Dec 2023
- Primary completion30 Aug 2027 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anterior Cruciate Ligament RuptureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Controlled, longitudinal, prospective, randomized, double-blind clinical trial that will include patients from the Luis Guillermo Ibarra-Ibarra National Rehabilitation Institute (INRLGII) of the Sports Orthopedics and Arthroscopy service, with primary ACL injury who undergo surgery with a consistent procedure in ACL reconstruction either with the use of bone tendon bone graft or quadriceps tendon with bone pad in the period from October 2023 to October 2025.
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Instituto Nacional de Rehabilitacion
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Dr. Félix Enrique Villalobos Córdova, Instituto Nacional de Rehabilitacion
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06189573
- Sponsor's protocol ID
- Por asignar
- Status last verified
- May 2025
- First submitted
- 2 Dec 2023
- Last updated
- 30 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reconstruction of the Anterior Cruciated Ligament With Quadriceps Tendon Graft With Bone Plug vs Bone Patellar Tendon Bone Graft, a Randomized Clinical Controlled Essay With 2 Years of Follow up
- ClinicalTrials.gov ID
- NCT06189573
- Acronym / sponsor ID
- Por asignar
- Conditions
- Anterior Cruciate Ligament Rupture
- Keywords
- Anterior Cruciate Ligament Reconstruction, Bone patellar tendon bone graft, Quadriceps tendon graft, KT-1000, IKDC
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Instituto Nacional de RehabilitacionOther government
- Study start
- 18 Dec 2023 (actual)
- Primary completion
- 30 Aug 2027 (estimated)
- Study completion
- 30 Dec 2027 (estimated)
- First posted
- 3 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Anterior cruciate ligament (ACL) injury is one of the most common orthopedic injuries worldwide. Currently, the use of the bone patellar tendon bone graft (BPTB) technique is considered the gold standard. The use of the quadriceps tendon graft (QT) has gained greater interest in recent years, this because with an adequate technique it is possible to obtain a biomechanically superior graft with fewer adverse events. The objective of this study is to compare the objective and subjective clinical results, as well as the presence or not of adverse events in ACL reconstruction with these 2 types of grafts in the medium term.
Materials and methods: Controlled, longitudinal, prospective, randomized, double-blind clinical trial that will include patients of both sexes, between 15 and 55 years of age, with primary ACL injury who attend the outpatient clinic of the Sports Orthopedics Service. INRLGII arthroscopy between October 2023 and October 2025, prior informed consent. Graft selection will be done randomly 1:1 between bone-tendon-bone (BPTB) graft Vs. quadriceps tendon graft (QT) for ACL reconstruction surgery. The clinical evaluation of the patients Will be done by 2 blinded evaluators, through the objective measurement of KT-1000 and the use of subjective clinical knee scales, both preoperatively and at 3-6-12 and 24 months. The presence or absence of adverse events or complications will be documented during a minimum of 2 years of follow-up. Parametric and non-parametric statistical tests will be used depending on whether the distribution is normal or not, for dependent and independent groups, using the SPSS version 25 statistical program.
Detailed description
JUSTIFICATION ACL rupture is one of the most frequent and studied injuries in orthopedic literature. Various short-, medium- and long-term results of ACL reconstruction have been described in the international literature, as well as comparisons between different types of reconstruction techniques, grafts and complications.
The vast majority of studies and clinical trials focus on BPTB and hamstrings tendon (HT), the former being considered by multiple authors as the gold standard for the management of these injuries despite its association with high donor site morbidity such as anterior knee pain, pain when kneeling and muscle weakness.
With an adequate surgical technique for both graft harvesting and ACL reconstruction, the use of QT as a graft has reported good biomechanical and clinical results and even superior to other grafts. However, despite this, at present a precise justification has not been established that defines the advantages or disadvantages of choosing this graft over other popular techniques, which is why a randomized study was carried out in a center of high specialty and concentration of patients with this type of lesions will increase the level of scientific validation of the information available regarding the use of this graft.
PROBLEM STATEMENT Is there a statistically significant difference between both techniques (BPTB and QT) at 2 years? Minimum follow-up regarding clinical evolution measured with IKDC, objective stability measured by KT-1000, and adverse events in primary ACL reconstruction?
HYPOTHESIS In patients with anterior cruciate ligament (ACL) injury who undergo surgery reconstruction with the use of autologous quadriceps tendon with bone plug (QT) or bone patellar tendon bone (BPTB) graft, there will be no statistically significant difference between them, in the first 2 years of follow-up, in terms of clinical evolution measured by the International subjective scale Knee Documentation Committee (IKDC), nor objective stability measured by arthrometry with the KT1000 device; In addition, there will be fewer adverse events in patients in whom quadriceps tendon graft (QT) was used compared to bone patellar tendon bone graft (BPTB).
GENERAL OBJECTIVE Observe if there is a statistically significant difference between both QT and BPTB grafts in terms of clinical evolution measured by IKDC, and objective stability measured by KT-1000, as well as reporting adverse events in both groups at 2 years of follow-up.
MATERIAL AND METHODS Controlled, longitudinal, prospective, randomized, double-blind clinical trial that will include patients from the Luis Guillermo Ibarra-Ibarra National Rehabilitation Institute (INRLGII) of the Sports Orthopedics and Arthroscopy service, with primary ACL injury who undergo surgery with a consistent procedure in ACL reconstruction either with the use of bone patellar tendon bone graft or quadriceps tendon with bone pad in the period from October 2023 to October 2025. When a patient who requires ACL reconstruction surgery is scheduled in our service, if he meets With the inclusion criteria, you will be invited to participate in the study and if you accept and give your written informed consent you will be included in the study. The selection of the graft to be used will be carried out randomly with a box with a closed envelope, which contains the same number of envelopes with one or another type of graft, and the resulting option will be the way in which the type of graft is assigned. graft, which will not be disclosed to the patient during the period of the study. During the surgical procedure, the repair of concomitant injuries (meniscal or chondral) will be carried out, and at the end of the surgery, the surgeon will prepare the surgical report sheet detailing the findings found and the characteristics of the graft used in terms of thickness, length , and the presence or absence of incidents during surgery.
Subjective clinical scales from IKDC, Kujala, Lysholm, Tegner, and KOOS will be applied. Measurement of the anterior translation of the tibia will be performed objectively with the use of the KT-1000 device.
Subjective and objective clinical evaluations with KT-1000 will be carried out preoperatively and postoperatively at 3, 6, 12 and 24 months by 2 evaluators who will be blinded to the type of graft used in each patient, for which the anterior part of his knee will be covered with a 20cm long "micropore" band, so that the type of graft cannot be identified by the evaluator based on the area of the knee and surgical scar. Clinical follow-up of the patient will also be carried out, in the necessary weeks or months at the discretion of the surgeon or treating doctor, as is usually carried out in the clinical practice of the institute.
Non-contrast magnetic resonance imaging (MRI) studies will be performed to evaluate the integrity of the ACL graft, by an orthopedic evaluator with experience in musculoskeletal imaging, blinded to the type of graft used, to classify it as: intact graft, graft with partial injury to its fibers or graft with complete injury to its fibers. Knee radiographs will also be performed (AP projection in standing position, lateral at 30° of flexion and axial of the patella at 40°), preoperatively and 12 and 24 months after surgery, which will be evaluated by an orthopedic evaluator with experience in musculoskeletal imaging. , blinded to the type of graft used, to evaluate the presence or absence of Osteoarthritis according to the Kellgren \& Lawrence classification, in grades 0 to 4.
All patients will be subjected to the same rehabilitation protocol during the first 3-4 months after surgery, as well as follow-up by sports medicine both pre-surgery and from the 3rd to 4th post-surgical month to receive the same muscle strengthening protocol established in our Institute for patients undergoing ACL reconstruction surgery. Keeping a record of the evaluation of preoperative and postoperative quadriceps strength in a standardized and objective manner through isokinetic evaluation with Cybex.
The use of a mechanical knee brace locked to the operated on knee will not be required on a routine basis, unless there is some indication of its use by the treating surgeon to protect associated injuries that require it, and in that case the use of It will be for a period of no more than 6 weeks. Patients must perform assisted ambulation with the use of crutches for the first 2 weeks with partial support of the operated leg and will subsequently progress to full support, as long as there is no contraindication on the part of the treating surgeon in relation to the management of associated injuries.
The presence or absence of adverse events or complications will be documented during 2 years of minimal monitoring. Parametric and non-parametric statistical tests will be used depending on whether the case has a normal distribution or not, for dependent and independent groups, of the related variables that are the result of periodic evaluations (3, 6, 12 and 24 months) of the same technique. either QT or BPTB, using the SPSS statistical program version 25.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 2
- Model description
- Controlled, longitudinal, prospective, randomized, double-blind clinical trial that will include patients from the Luis Guillermo Ibarra-Ibarra National Rehabilitation Institute (INRLGII) of the Sports Orthopedics and Arthroscopy service, with primary ACL injury who undergo surgery with a consistent procedure in ACL reconstruction either with the use of bone tendon bone graft or quadriceps tendon with bone pad in the period from October 2023 to October 2025.
| Arm | Type | Receives |
|---|---|---|
| Quadriceps Tendon graft | Other | Procedure: Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graftPatients with ACL reconstruction with the use of quadriceps tendon graft |
| Bone Patellar Tendon Bone Graft | Other | Procedure: Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graftPatients with ACL reconstruction with the use of bone patellar tendon bone graft |
Who may qualify
- Ages
- 15 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Men and women from 15 to 55 years old.
- Primary ACL rupture diagnosed by MRI.
- INR-LGII patients with a complete institutional record.
- Without the presence of systemic, chronic degenerative comorbidities that could affect the quality of the graft. (Diabetes, Thyroid, Autoimmune diseases).
Key exclusion criteria (21 listed)
- Grade 2 or 3 posterior cruciate ligament injuries.
- Multiligamentous injuries.
- Severe varus/valgus deformities (mechanical axis outside the range of 35% to 65% of the articular surface of the tibia).
- Previous knee surgeries to be treated.
- Anterior knee pain present (VAS greater than 6), with brush and escape maneuvers positive.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graftSurgical reconstruction of anterior cruciate ligament with autologous quadriceps tendon graft | Procedure or surgery | Quadriceps Tendon graft |
| Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graftSurgical reconstruction of anterior cruciate ligament with autologous bone patellar tendon bone graft | Procedure or surgery | Bone Patellar Tendon Bone Graft |
Primary outcome
International Knee Documentation Committee score (IKDC)
Time frame: Presurgical, 3, 6, 12 and 24 postsurgical months
Minimum value 0 Maximum value 100 Higher scores mean a better outcome Subjective assesment. Three categories are examined by the questionnaire: symptoms, athletic activity, and knee function
KT-1000
Time frame: Presurgical, 3, 6, 12 and 24 postsurgical months
Device for objective stability measurement.
4 secondary outcomes
Anterior Knee Pain Scale (Kujala score)
Time frame: Presurgical, 3, 6, 12 and 24 postsurgical months
Lysholm Knee Scoring Scale
Time frame: Presurgical, 3, 6, 12 and 24 postsurgical months
Tegner Activity Scoring Scale
Time frame: Presurgical, 3, 6, 12 and 24 postsurgical months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time frame: Presurgical, 3, 6, 12 and 24 postsurgical months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 May 2025.
Related trials for Anterior Cruciate Ligament Rupture
Not yet recruiting
Supporting Athletes' Return to Sports After ACL Reconstruction: A Study of a Psychological Readiness Program
Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries
Not yet recruiting
Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Not yet recruitingPhase 3
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
RecruitingObservational study
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
ACL Tears
RecruitingPhase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
Osteoarthritis, Knee, Post-traumatic Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Anterior cruciate ligament Reconstruction with autologous quadriceps tendon graft and Anterior cruciate ligament Reconstruction with autologous bone patellar tendon bone graft in people with Anterior Cruciate Ligament Rupture, run by Instituto Nacional de Rehabilitacion at 1 site in Mexico.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 30 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
International Knee Documentation Committee score (IKDC) (time frame: Presurgical, 3, 6, 12 and 24 postsurgical months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2025.